What is Apollomics Inc. Warrant?
, a biotechnology company, engages in the discovery and development of mono and combination oncology therapies to harness the immune system and target specific molecular pathways to inhibit cancer.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
, a biotechnology company, engages in the discovery and development of mono and combination oncology therapies to harness the immune system and target specific molecular pathways to inhibit cancer. Its pipeline consists of various development-stage assets, including novel and humanized monoclonal antibodies that restore the body's immune system to recognize and kill cancer cells, and targeted therapies against uncontrolled growth signaling pathways. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 49.06M.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.